Open Access
Table 1
Study design and fecal examination methods for all the time-points of fecal collection in 23 dogs.
FS1 | Treatment | FS2 | FS3 | |
---|---|---|---|---|
Day of collection | 0–4 days before the initiation of treatment | Fenbendazole 50 mg/kg BW once daily for 5 consecutive days + disinfection of dog and environment | 2–4 days after the end of treatment | 8–10 days after the end of treatment |
Fecal consistency (number of dogs with diarrhea/intermittent/no diarrhea) | 21/0/2 | 5/11/7 | 9/4/10 | |
Fecal flotation (positive/negative results) | 23/0 | 19/4 | 17/5 | |
Direct immunofluorescence assay (geometrical mean) | 213,989 cpg (IQR = 97,500–555,600) | 34,147 cpg (IQR = 9675–333,600) | 57,239 cpg (IQR = 12,000–456,000) | |
Molecular typing by PCR (C/D/C + D) | 15/4/0 | 14/5/1 | Not evaluated |
BW: body weight, cpg: cysts per gram, IQR: interquartile range, PCR: polymerase chain reaction.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.